Sinopharm
E335747
Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
All labels observed (7)
| Label | Occurrences |
|---|---|
| China National Biotec Group | 1 |
| China National Pharmaceutical Group Corporation | 1 |
| Sinopharm canonical | 1 |
| Sinopharm BIBP COVID-19 vaccine | 1 |
| Sinopharm CNBG | 1 |
| Sinopharm Group Co., Ltd. | 1 |
| Sinopharm WIBP COVID-19 vaccine | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T3205351 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Sinopharm Context triple: [COVID-19 pandemic, majorVaccineDeveloper, Sinopharm]
-
A.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Tsinan
Tsinan is an older romanized name for Jinan, the capital city of Shandong Province in eastern China known for its numerous natural springs.
-
D.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Sinopharm Target entity description: Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
-
A.
Fosun International
Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
-
B.
Chugai Pharmaceutical
Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
-
C.
Tsinan
Tsinan is an older romanized name for Jinan, the capital city of Shandong Province in eastern China known for its numerous natural springs.
-
D.
BioNTech
BioNTech is a German biotechnology company best known for developing one of the first mRNA-based COVID-19 vaccines in partnership with Pfizer.
-
E.
Roche
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
- F. None of above. chosen
Statements (46)
| Predicate | Object |
|---|---|
| instanceOf |
pharmaceutical company
ⓘ
state-owned enterprise ⓘ vaccine manufacturer ⓘ |
| abbreviationOf |
Sinopharm
self-linksurface differs
ⓘ
surface form:
China National Pharmaceutical Group Corporation
|
| collaboratesWith |
World Health Organization
ⓘ
various national health ministries ⓘ |
| country | China ⓘ |
| developed |
BBIBP-CorV
ⓘ
Sinopharm self-linksurface differs ⓘ
surface form:
Sinopharm BIBP COVID-19 vaccine
Sinopharm self-linksurface differs ⓘ
surface form:
Sinopharm WIBP COVID-19 vaccine
|
| distributes |
BBIBP-CorV
ⓘ
Sinopharm BIBP COVID-19 vaccine ⓘ Sinopharm BIBP COVID-19 vaccine ⓘ
surface form:
Sinopharm WIBP COVID-19 vaccine
|
| focusesOn |
healthcare services
ⓘ
medical devices ⓘ pharmaceutical distribution ⓘ vaccine research and development ⓘ |
| foundedBy |
People's Republic of China government
ⓘ
surface form:
Chinese government
|
| hasBrand |
Sinopharm BIBP COVID-19 vaccine
ⓘ
surface form:
Sinopharm COVID-19 vaccine
|
| hasBusinessModel | research, manufacturing and distribution of pharmaceuticals ⓘ |
| hasDistributionNetwork | nationwide pharmaceutical distribution network in China ⓘ |
| hasSubsidiary |
Sinopharm
self-linksurface differs
ⓘ
surface form:
China National Biotec Group
Sinopharm self-linksurface differs ⓘ
surface form:
Sinopharm CNBG
Sinopharm self-linksurface differs ⓘ
surface form:
Sinopharm Group Co., Ltd.
|
| headquartersLocation | Beijing ⓘ |
| industry |
biotechnology
ⓘ
healthcare ⓘ pharmaceutical industry ⓘ |
| languageOfName | Chinese ⓘ |
| market |
domestic Chinese market
ⓘ
international vaccine market ⓘ |
| notableWork | development of inactivated COVID-19 vaccines ⓘ |
| owner |
People's Republic of China government
ⓘ
surface form:
Chinese government
|
| parentOrganization | State-owned Assets Supervision and Administration Commission of the State Council ⓘ |
| productType |
COVID-19 vaccine
ⓘ
inactivated virus vaccine ⓘ |
| received | World Health Organization emergency use listing for BBIBP-CorV ⓘ |
| regulatoryStatus | subject to regulation by Chinese National Medical Products Administration ⓘ |
| role |
key participant in China’s COVID-19 vaccination campaign
ⓘ
major supplier of COVID-19 vaccines to developing countries ⓘ |
| sector | public sector ⓘ |
| suppliedTo |
African countries
ⓘ
Asian countries outside China ⓘ Latin American countries ⓘ Middle East countries ⓘ |
| vaccinePlatform | inactivated whole-virus platform for COVID-19 vaccines ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: Sinopharm Description of subject: Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
Referenced by (7)
Full triples — surface form annotated when it differs from this entity's canonical label.
this entity surface form:
China National Biotec Group
this entity surface form:
Sinopharm Group Co., Ltd.
this entity surface form:
Sinopharm CNBG
this entity surface form:
Sinopharm BIBP COVID-19 vaccine
this entity surface form:
Sinopharm WIBP COVID-19 vaccine
this entity surface form:
China National Pharmaceutical Group Corporation